-
GSK 2837808A LDHA Inhibition Workflow
2026-08-28
GSK 2837808A enables focused interrogation of LDHA-driven lactate production, glucose use, and immunometabolic signaling without treating glycolysis as a single undifferentiated process. This workflow separates validated hepatocellular carcinoma applications from exploratory colorectal cancer studies and provides practical assay, dosing, and troubleshooting guidance.
-
LY2228820: p38 MAP Kinase Inhibitor Workflow
2026-08-27
Build cleaner inflammation, angiogenesis, and cancer research experiments with LY2228820, a selective ATP-competitive p38 MAP kinase inhibitor. This practical guide connects target engagement, phospho-MK2 measurements, cytokine profiling, apoptosis assay design, and airway-rest-enosis-inspired translational questions without overstating the current evidence.
-
Lanabecestat: Designing Better BACE1 Assays
2026-08-27
Lanabecestat (AZD3293) is a potent, brain-penetrant BACE1 inhibitor for Alzheimer's disease research. This guide presents an assay-centered framework for linking amyloid-beta production inhibition with synaptic function, exposure, and experimental interpretation.
-
Cy5-UTP: From Labeling Chemistry to RNA Readouts
2026-08-26
Cy5-UTP enables direct, sensitive RNA visualization through fluorescent nucleotide incorporation during in vitro transcription. This guide connects Cyanine 5-uridine triphosphate chemistry with assay design, riboswitch research, FISH, and quantitative probe workflows.
-
Lactate–GPR81–Rac1 and Insulin-Independent Glucose Uptake
2026-08-26
A 2026 Cell Research study identifies lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and defines a GPR81–FARP1–RAC1 mechanism that promotes GLUT4 translocation. The work connects exercise-associated lactate production with glucose control and provides a framework for testing metabolic pathways that operate alongside, rather than through, canonical insulin–AKT signaling.
-
NSC23766 trihydrochloride for Cell Assays
2026-08-25
Learn how NSC23766 trihydrochloride, SKU A1952, can improve the design and interpretation of Rac1-focused viability, proliferation, apoptosis, and glucose-uptake experiments. This scenario-based guide connects product handling data with practical controls, assay compatibility, and limitations documented in current literature.
-
Homoharringtonine: From Translation to Assay Design
2026-08-25
Homoharringtonine is a cytotoxic alkaloid whose ribosome-level activity connects leukemia research with emerging SARS-CoV-2 antiviral research. This mechanism-focused guide explains how to design, interpret, and control assays around its powerful but nonselective translation-inhibitory effects.
-
(-)-Blebbistatin for Mechanobiology Assays
2026-08-24
Use (-)-Blebbistatin to separate non-muscle myosin II-dependent force transmission from stress-fiber architecture in live-cell mechanobiology workflows. This practical guide connects controlled magnetic stimulation with cytoskeletal, chromatin, migration, and contractility readouts while emphasizing dose selection, reversibility, and troubleshooting.
-
TAK-715: A Selective p38 MAPK Inhibitor Workflow
2026-08-24
TAK-715 combines nanomolar p38α inhibition with a practical workflow for dissecting cytokine signaling, inflammatory transcription, and kinase dephosphorylation. This guide connects cell-based assays, phosphatase-aware experiments, and rheumatoid arthritis research while emphasizing solvent control, endpoint selection, and troubleshooting.
-
Acetylcysteine Workflows for Redox Research
2026-08-23
Build reproducible Acetylcysteine assays for oxidative stress, hepatic protection, respiratory mucus, and neurodegeneration research. This practical guide connects NAC dosing and controls with assay choices inspired by a photothermal-immunotherapy platform, while clearly separating established evidence from testable extensions.
-
Lithium, Exosomal Wnt10a, and Bone Formation
2026-08-22
The reference study identifies a mechanistic pathway in which lithium enhances Rab11a/Rab11FIP1-dependent exosomal Wnt10a secretion from bone mesenchymal stem cells, activating β-catenin signaling in recipient cells. Its Li-Exo-functionalized GelMA hydrogel provides a practical framework for engineering stem-cell-derived exosomes to improve osteogenesis and bone repair.
-
Oral Colon Cancer Therapy with Dextran Microgels
2026-08-22
The reference study develops a sequentially targeted oral system that combines dextran microgels with cisplatin/SPION lipid nanoparticles for localized colon cancer treatment. Its design integrates colon-selective release, folate-receptor-mediated cellular uptake, chemotherapy, and magnetothermal therapy to reduce tumor growth and peritoneal dissemination in an orthotopic mouse model.
-
AmpliFold Capture-and-Release in Lateral Flow Assays
2026-08-21
The ChemRxiv study introduces AmpliFold, a triggered capture-and-release strategy that uses temporary sequestration and high-affinity rebinding to reduce the kinetic constraints of lateral flow assays. In a HER2 model, the approach improved analytical sensitivity by enlarging the effective capture region and produced up to 16-fold and 12-fold gains under different assay configurations.
-
α-Linolenic Acid: Applied Research Workflows
2026-08-20
α-Linolenic Acid (ALA) provides a practical way to interrogate fatty-acid handling, membrane remodeling, and cardiovascular or inflammatory phenotypes in controlled models. This workflow-focused guide covers stock preparation, dose finding, lipidomics-compatible sampling, and a cautious framework for translating findings from recent arachidonic-acid immunology research.
-
How Impending Cell Death Creates Metastatic States
2026-08-20
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending-death experience can become stable prometastatic cells called PAMEs. Their work links ER stress, PERK-CHOP signaling, NANOG- and GLI-associated reprogramming, and a cytokine-mediated interaction with neighboring PIM cells to the emergence of metastasis.